Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Abhishek Bose is active.

Publication


Featured researches published by Abhishek Bose.


Journal of Cardiovascular Electrophysiology | 2014

Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.

Abhishek Bose; Jagdesh Kandala; Gaurav A. Upadhyay; Lindsay Riedl; Imad Ahmado; Ram Padmanabhan; Henry Gewirtz; Lawrence J. Mulligan; Jagmeet P. Singh

Cardiac resynchronization therapy (CRT) recipients with ischemic cardiomyopathy (ICM) have scar segments that may limit ventricular resynchronization and clinical response. The impact of myocardial viability at the left ventricular (LV) pacing site on CRT response is poorly elucidated.


Heart Rhythm | 2015

Prognostic implication of baseline PR interval in cardiac resynchronization therapy recipients

Łukasz Januszkiewicz; Eszter M. Vegh; Rasmus Borgquist; Abhishek Bose; Ajay K. Sharma; Theofanie Mela; Jagmeet P. Singh; Kimberly A. Parks

BACKGROUND Prolongation of the baseline ECG PR interval is frequently encountered among cardiac resynchronization therapy (CRT) recipients. There are conflicting data regarding the association of a prolonged PR interval with long-term clinical outcome in this patient group. OBJECTIVE The purpose of this study was to compare clinical outcomes and response to CRT in patients with normal (<200 ms) vs prolonged (≥200 ms) baseline PR interval. METHODS In this study, 283 patients (normal PR interval: n = 158; prolonged PR interval: n = 125) with documented baseline intrinsic PR interval were followed for 3 years after CRT implantation. The study population consisted of 24.7% women (mean age 66 ± 13 years, left ventricular ejection fraction 24% ± 7%). RESULTS A Cox proportional hazard model identified baseline PR interval as a predictor of the composite end-point (all-cause mortality, heart failure hospitalization, left ventricular assist device implantation, and heart transplantation) in univariate analysis (hazard ratio [HR] 1.49, 95% confidence interval [CI] 1.02-2.17, P = .04) but not in multivariate analysis. It also predicted heart failure hospitalization in univariate (HR 1.6, 95% CI 1.1-2.4, P = .02) and multivariate analysis (HR 1.6, 95% CI 1.0-2.3, P = .03). A prolonged PR interval was associated with lower probability of reverse remodeling defined as ≥10% improvement in ejection fraction (64% vs 77%, P = .057), especially in patients with non-left bundle branch block ECG morphology (41% vs 68%, P = .03). CONCLUSION Among patients with CRT, a prolonged baseline PR interval is an independent predictor of worse prognosis and lower probability of reverse remodeling, especially for patients with non-left bundle branch block morphology on ECG.


Journal of Cardiovascular Electrophysiology | 2013

Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy.

Jagdesh Kandala; Gaurav A. Upadhyay; Robert K. Altman; Abhishek Bose; E. Kevin Heist; Theofanie Mela; Jagmeet P. Singh

Electrical Delay in Apically Positioned LV Leads. Introduction: In recent studies, an anatomical apical left ventricular (LV) lead pacing location has been associated with deleterious outcome after cardiac resynchronization therapy (CRT). The differential impact of the LV lead electrical location in these patients remains unknown.


Journal of Interventional Cardiac Electrophysiology | 2015

Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.

Abhishek Bose; Quynh A. Truong; Jagmeet P. Singh

Circulating biomarkers related to inflammation, neurohormones, myocardial stress, and necrosis have been associated with commonly encountered arrhythmic disorders such as atrial fibrillation (AF) and more malignant processes including ventricular arrhythmias (VA) and sudden cardiac death (SCD). Both direct and indirect biomarkers implicated in the heart failure cascade have potential prognostic value in patients undergoing cardiac resynchronization therapy (CRT). This review will focus on the role of biomarkers in AF, history of SCD, and CRT with an emphasis to improve clinical risk assessment for arrhythmias and patient selection for device therapy. Notably, information obtained from biomarkers may supplement traditional diagnostic and imaging techniques, thus providing an additional benefit in the management of patients.


Journal of Cardiovascular Electrophysiology | 2014

Does Prior Valve Surgery Change Outcome in Patients Treated with Cardiac Resynchronization Therapy

Abhishek Bose; Gaurav A. Upadhyay; Jagdesh Kandala; Edwin Kevin Heist; Theofanie Mela; Kimberly A. Parks; Jagmeet P. Singh

Cardiac valve surgery (CVS) has been implicated as a potential barrier to optimal response after cardiac resynchronization therapy (CRT) though prospective data regarding outcome remains limited. We sought to determine CRT response in patients with a prior history of CVS.


Journal of the American College of Cardiology | 2012

ANGIOGRAPHIC AND NUCLEAR IMAGING PREDICTORS OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY (CRT) IN ISCHEMIC CARDIOMYOPATHY

Abhishek Bose; Jagdesh Kandala; Gaurav A. Upadhyay; Imad Ahmado; Robert K. Altman; Lindsay Riedl; Lawrence J. Mulligan; Jagmeet P. Singh

Although scar has been associated with poor outcome after CRT, the impact of coronary artery disease (CAD) severity or ischemia on CRT response remains uncertain. A prospective cohort of CRT patients with ischemic cardiomyopathy was evaluated for ischemia and scar with nuclear perfusion imaging.


Circulation | 2016

Abstract 12823: Estimated Cardiorespiratory Fitness and Incident Atrial Fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study

Abhishek Bose; Wesley T. O’Neal; Aleena Bennett; Suzanne E. Judd; Waqas Qureshi; Xuemei Sui; Virginia J. Howard; George Howard; Elsayed Z. Soliman


/data/revues/00029149/unassign/S0002914914009631/ | 2014

Usefulness of Hyponatremia as a Predictor for Adverse Events in Patients With Heart Failure Receiving Cardiac Resynchronization Therapy

Ajay K. Sharma; Eszter M. Vegh; Jagdesh Kandala; Lukasz Januszkiewicz; Abhishek Bose; Alexandra Miller; Kimberly A. Parks; E. Kevin Heist; Jagmeet P. Singh


Circulation-cardiovascular Quality and Outcomes | 2013

Abstract 259: The Role of Gender in Cardiac Resynchronization Therapy Response in Patients with Optimal Anatomical and Electrical Left Ventricular Lead Location.

Abhishek Bose; Jagdesh Kandala; Jagmeet P. Singh


Circulation | 2013

Abstract 14116: Myocardial Viability and Left Ventricular Lead location as Predictors of Ventricular Arrhythmias in Cardiac Resynchronization Therapy (CRT) Recipients With Ischemic Cardiomyopathy

Abhishek Bose; Jagdesh Kandala; Daniel J. Friedman; Alefiyah Rajabali; Eszter M. Vegh; E. Kevin Heist; Theofanie Mela; Jagmeet P. Singh

Collaboration


Dive into the Abhishek Bose's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ajay K. Sharma

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge